Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.57% | 93.76 | 1.3% | $988.46m | |
| BIIB | Biogen Inc. | -0.35% | 226.39 | 1.3% | $918.49m | |
| AMGN | Amgen Inc. | -2.74% | 177.47 | 1.3% | $453.25m | |
| GILD | Gilead Sciences, Inc. | -0.47% | 62.95 | 0.9% | $425.78m | |
| ILMN | Illumina, Inc. | 0.11% | 319.03 | 3.5% | $281.76m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.81% | 333.34 | 2.6% | $254.55m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.71% | 168.16 | 1.9% | $234.34m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.08% | 126.01 | 2.0% | $171.81m | |
| ONCE | Spark Therapeutics, Inc. | -0.08% | 110.62 | 11.2% | $168.65m | |
| EXAS | Exact Sciences Corporation | 0.44% | 92.21 | 25.3% | $159.85m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.76% | 116.64 | 14.7% | $146.14m | |
| A | Agilent Technologies, Inc. | 0.99% | 76.18 | 1.6% | $127.24m | |
| INCY | Incyte Corporation | -0.48% | 73.96 | 2.5% | $94.31m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.44% | 72.99 | 8.3% | $92.09m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.98% | 83.16 | 4.3% | $89.34m |
Company Profile
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.